LAURUS LABS LTD (LAURUSLABS.NS) Financials
LAURUSLABS.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 80.6 billion | 40.1 billion |
| 2023-06-30 | ? | ? |
| 2023-03-31 | 76.6 billion | 36.1 billion |
LAURUSLABS.NS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 2.0 billion | ? |
| 2023-09-30 | 1.9 billion | ? |
| 2023-06-30 | 1.8 billion | ? |
| 2023-03-31 | 74.8 million | 74.8 million |
LAURUSLABS.NS Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 231.4 million |
| 2023-09-30 | 369.5 million |
| 2023-06-30 | 248.5 million |
| 2023-03-31 | 1.0 billion |
LAURUSLABS.NS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | 819.5 million | 6.9 billion | 467.3 million |
| 2023-06-30 | 484.6 million | - | - |
| 2023-03-31 | 647.7 million | 8.0 billion | 431.2 million |
LAURUSLABS.NS Shares Outstanding
LAURUSLABS.NS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | 670.0 million | - | - |
| 2023-09-30 | 3.6 billion | 580.0 million | 1.6 billion | - |
| 2023-06-30 | - | 470.0 million | 1.6 billion | - |
| 2023-03-31 | 9.9 billion | 315.9 million | 2.2 billion | 166.0 million |
LAURUSLABS.NS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 11.9 billion | 5.5 billion |
| 2023-09-30 | 12.2 billion | 5.8 billion |
| 2023-06-30 | 11.8 billion | 5.8 billion |
| 2023-03-31 | 13.8 billion | 6.9 billion |
LAURUSLABS.NS
Price: ₹440.15
Dividend Yield: 0.00%
Forward Dividend Yield: 0.36%
Payout Ratio: 46.38%
Dividend Per Share: 1.60 INR
Earnings Per Share: 2.98 INR
P/E Ratio: 115.55
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 235.8 billion
Average Dividend Frequency: 2
Years Paying Dividends: 7
DGR3: -4.35%
DGR5: 30.00%